"country","World Bank economic status","Date tests last reported","Test positivity rate (%) in past year","Average daily tests in past year","% of cases sequenced in past year","Number of sequences in past year","Cumulative number of sequences entire pandemic","NGS facility access","COVID-19 diagnostic testing targets","SARS-CoV-2 sequencing targets","Test Archetype","Sequence Archetype"
"Afghanistan","Low income","March 31, 2022","21 %","0.04 per 1,000 persons","0.06 %","0.2 per 100k persons",94,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Albania","Upper middle income","March 23, 2022","12.2 %","1.17 per 1,000 persons","0.01 %","0.8 per 100k persons",52,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Algeria","Lower middle income","November 01, 2020","Insufficient data","Insufficient data","0.06 %","0.2 per 100k persons",120,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"American Samoa","Upper middle income","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Andorra","High income","March 01, 2022","19.9 %","5.09 per 1,000 persons","0.27 %","98.2 per 100k persons",77,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Angola","Lower middle income","April 01, 2022","7.2 %","0.09 per 1,000 persons","0.67 %","1.5 per 100k persons",1173,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Antigua and Barbuda","High income","June 07, 2021","5.6 %","0.35 per 1,000 persons","1.84 %","118.5 per 100k persons",128,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Argentina","Upper middle income","March 31, 2022","25.2 %","1.61 per 1,000 persons","0.17 %","24.8 per 100k persons",14847,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Armenia","Upper middle income","April 01, 2022","10.9 %","1.97 per 1,000 persons","0.05 %","3.7 per 100k persons",191,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Aruba","High income","No tests reported","Insufficient data","Insufficient data","9.78 %","2238.9 per 100k persons",3020,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Australia","High income","April 01, 2022","8.9 %","5.46 per 1,000 persons","1.19 %","213.1 per 100k persons",75034,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Austria","High income","April 01, 2022","2.1 %","46.19 per 1,000 persons","2.26 %","826.9 per 100k persons",98266,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Azerbaijan","Upper middle income","April 01, 2022","13.9 %","1.04 per 1,000 persons","0 %","0.1 per 100k persons",151,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Bahrain","High income","April 01, 2022","6.8 %","9.75 per 1,000 persons","0.52 %","120.7 per 100k persons",2271,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Bangladesh","Lower middle income","April 01, 2022","14.7 %","0.15 per 1,000 persons","0.2 %","1.6 per 100k persons",4313,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Barbados","High income","April 01, 2022","11.8 %","4.48 per 1,000 persons","0.15 %","28.2 per 100k persons",92,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Belarus","Upper middle income","April 01, 2022","8.6 %","2.17 per 1,000 persons","0.03 %","2.1 per 100k persons",255,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Belgium","High income","April 01, 2022","13.5 %","5.14 per 1,000 persons","2.5 %","638 per 100k persons",91377,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Belize","Upper middle income","March 29, 2022","10.6 %","2.9 per 1,000 persons","1.06 %","117.6 per 100k persons",585,"Does not have access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Benin","Lower middle income","January 25, 2022","2.8 %","0.08 per 1,000 persons","1.87 %","2.9 per 100k persons",777,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Bermuda","High income","April 01, 2022","No cases reported","28.37 per 1,000 persons","0.51 %","93.4 per 100k persons",98,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Bhutan","Lower middle income","March 01, 2022","1.1 %","4.39 per 1,000 persons","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Bolivia","Lower middle income","January 02, 2022","15.8 %","0.66 per 1,000 persons","0.01 %","0.3 per 100k persons",175,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Bolivia","Lower middle income","January 02, 2022","15.8 %","0.66 per 1,000 persons","0.01 %","0.3 per 100k persons",175,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Bosnia and Herzegovina","Upper middle income","April 01, 2022","30 %","0.58 per 1,000 persons","0.61 %","38.1 per 100k persons",1348,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Botswana","Upper middle income","March 17, 2022","17.3 %","1.56 per 1,000 persons","0.79 %","86.7 per 100k persons",2353,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Brazil","Upper middle income","March 11, 2022","40.5 %","0.56 per 1,000 persons","0.54 %","42.7 per 100k persons",108591,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"British Virgin Islands","High income","No tests reported","Insufficient data","Insufficient data","1.18 %","233.4 per 100k persons",82,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Brunei","High income","December 14, 2021","2.7 %","4.89 per 1,000 persons","0.87 %","265.7 per 100k persons",1183,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Brunei","High income","December 14, 2021","2.7 %","4.89 per 1,000 persons","0.87 %","265.7 per 100k persons",1183,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Bulgaria","Upper middle income","April 01, 2022","10.7 %","2.96 per 1,000 persons","1.09 %","125.9 per 100k persons",10958,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Burkina Faso","Low income","March 09, 2022","5.2 %","0.02 per 1,000 persons","0.87 %","0.3 per 100k persons",611,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Burundi","Low income","March 31, 2022","2.8 %","0.29 per 1,000 persons","0.18 %","0.5 per 100k persons",63,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Cambodia","Lower middle income","March 31, 2022","6 %","0.37 per 1,000 persons","1.76 %","13.8 per 100k persons",2437,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Cameroon","Lower middle income","March 24, 2022","4.9 %","0.15 per 1,000 persons","0.69 %","1.6 per 100k persons",645,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Canada","High income","April 01, 2022","7.8 %","2.32 per 1,000 persons","8.58 %","565.1 per 100k persons",288201,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Cape Verde","Lower middle income","March 31, 2022","11.9 %","1.6 per 1,000 persons","0.3 %","20.6 per 100k persons",163,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Cayman Islands","High income","No tests reported","Insufficient data","Insufficient data","0.31 %","94.7 per 100k persons",97,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Central African Republic","Low income","March 24, 2022","19.7 %","0.03 per 1,000 persons","0.39 %","0.8 per 100k persons",97,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Chad","Low income","March 31, 2022","2.8 %","0.02 per 1,000 persons","0.8 %","0.1 per 100k persons",22,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Chile","High income","April 01, 2022","10.2 %","3.48 per 1,000 persons","0.74 %","95 per 100k persons",20194,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"China","Upper middle income","June 24, 2020","Insufficient data","Insufficient data","0.25 %","0 per 100k persons",1442,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Colombia","Upper middle income","March 31, 2022","17.4 %","1.14 per 1,000 persons","0.32 %","23.2 per 100k persons",12951,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Comoros","Lower middle income","November 27, 2020","Insufficient data","Insufficient data","0.32 %","1.6 per 100k persons",20,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Costa Rica","Upper middle income","March 30, 2022","19.2 %","1.74 per 1,000 persons","0.36 %","43.2 per 100k persons",2831,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Croatia","High income","March 31, 2022","26.4 %","2.1 per 1,000 persons","2.57 %","521.2 per 100k persons",24068,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Cuba","Upper middle income","April 01, 2022","9.7 %","2.53 per 1,000 persons","0.07 %","6.3 per 100k persons",1159,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Cura√ßao","High income","No tests reported","Insufficient data","Insufficient data","3.17 %","611.7 per 100k persons",1271,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Cyprus","High income","July 11, 2021","0.7 %","43.69 per 1,000 persons","0 %","0.1 per 100k persons",728,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Czech Republic","High income","April 01, 2022","5.4 %","10.87 per 1,000 persons","1.09 %","231.8 per 100k persons",28196,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Democratic Republic of the Congo","Low income","April 01, 2022","7 %","0.03 per 1,000 persons","0.4 %","0.3 per 100k persons",810,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Denmark","High income","March 30, 2022","2.8 %","48.22 per 1,000 persons","12.97 %","6313.2 per 100k persons",443484,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Djibouti","Lower middle income","April 01, 2022","4.7 %","0.47 per 1,000 persons","6.06 %","44.8 per 100k persons",687,"Does not have access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Dominica","Upper middle income","December 28, 2021","5.9 %","5.62 per 1,000 persons","0.09 %","15.2 per 100k persons",20,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Dominican Republic","Upper middle income","September 23, 2021","14.2 %","0.38 per 1,000 persons","0.28 %","8.3 per 100k persons",1148,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"East Timor","Lower middle income","No tests reported","Insufficient data","Insufficient data","1.23 %","20.2 per 100k persons",355,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Ecuador","Upper middle income","February 01, 2022","31.2 %","0.24 per 1,000 persons","0.75 %","22.3 per 100k persons",4288,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Egypt","Lower middle income","March 31, 2022","8.5 %","0.1 per 1,000 persons","0.26 %","0.8 per 100k persons",1852,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"El Salvador","Lower middle income","March 18, 2022","9.5 %","0.44 per 1,000 persons","0.47 %","7 per 100k persons",460,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Equatorial Guinea","Upper middle income","March 31, 2022","4.8 %","0.37 per 1,000 persons","0.23 %","1.4 per 100k persons",212,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Eritrea","Low income","December 21, 2020","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Estonia","High income","April 01, 2022","21.4 %","4.34 per 1,000 persons","1.38 %","470.3 per 100k persons",9267,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Eswatini","Lower middle income","April 01, 2022","15.3 %","0.81 per 1,000 persons","0.42 %","18.6 per 100k persons",262,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Ethiopia","Low income","April 01, 2022","11.6 %","0.06 per 1,000 persons","0.19 %","0.4 per 100k persons",539,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Faroe Islands","High income","February 27, 2022","No cases reported","32.7 per 1,000 persons","0 %","2 per 100k persons",41,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Fiji","Upper middle income","April 01, 2022","13.8 %","1.43 per 1,000 persons","0.8 %","57 per 100k persons",531,"Does not have access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Finland","High income","April 01, 2022","12.2 %","3.2 per 1,000 persons","1.94 %","284.2 per 100k persons",25480,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"France","High income","April 01, 2022","11 %","8.11 per 1,000 persons","0.96 %","304.4 per 100k persons",251865,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"French Polynesia","High income","September 07, 2020","Insufficient data","Insufficient data","0.12 %","23.7 per 100k persons",94,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Gabon","Upper middle income","March 31, 2022","3 %","1.18 per 1,000 persons","0.58 %","7.1 per 100k persons",461,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Georgia","Upper middle income","June 16, 2021","8.7 %","2.75 per 1,000 persons","0.09 %","32.2 per 100k persons",1366,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Germany","High income","March 29, 2022","25.5 %","2.3 per 1,000 persons","2.39 %","528.1 per 100k persons",513616,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Ghana","Lower middle income","March 31, 2022","4.9 %","0.13 per 1,000 persons","2.7 %","6 per 100k persons",2736,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Gibraltar","High income","No tests reported","Insufficient data","Insufficient data","15.77 %","5963 per 100k persons",2800,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Greece","High income","April 01, 2022","4.1 %","17.62 per 1,000 persons","0.37 %","100 per 100k persons",14466,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Greenland","High income","August 25, 2021","No cases reported","4.19 per 1,000 persons","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Grenada","Upper middle income","January 23, 2022","11.6 %","2.85 per 1,000 persons","0.05 %","6.2 per 100k persons",13,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Guam","High income","No tests reported","Insufficient data","Insufficient data","Insufficient data","300.3 per 100k persons",586,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Guatemala","Upper middle income","April 01, 2022","20 %","0.48 per 1,000 persons","0.21 %","7.4 per 100k persons",1770,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Guinea","Low income","March 24, 2022","6.3 %","0.06 per 1,000 persons","1.29 %","1.6 per 100k persons",439,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Guinea-Bissau","Low income","March 31, 2022","6.4 %","0.1 per 1,000 persons","0 %","0 per 100k persons",46,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Guyana","Upper middle income","December 28, 2021","8.9 %","1.52 per 1,000 persons","0.09 %","6.3 per 100k persons",61,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Guyana","Upper middle income","December 28, 2021","8.9 %","1.52 per 1,000 persons","0.09 %","6.3 per 100k persons",61,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Haiti","Low income","No tests reported","Insufficient data","Insufficient data","0.43 %","0.7 per 100k persons",108,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Honduras","Lower middle income","December 22, 2021","31.6 %","0.23 per 1,000 persons","0.04 %","0.9 per 100k persons",119,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Hong Kong SAR, China","High income","March 29, 2022","No cases reported","12.17 per 1,000 persons","0.17 %","25.8 per 100k persons",6287,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Hungary","High income","April 01, 2022","18.4 %","1.86 per 1,000 persons","0 %","0.4 per 100k persons",473,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Iceland","High income","April 01, 2022","12.4 %","11.31 per 1,000 persons","2.41 %","1146.4 per 100k persons",9831,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"India","Lower middle income","April 01, 2022","5.7 %","1.08 per 1,000 persons","0.34 %","7.5 per 100k persons",131334,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Indonesia","Upper middle income","April 01, 2022","5.4 %","0.83 per 1,000 persons","0.31 %","5 per 100k persons",16431,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Iran","Upper middle income","April 01, 2022","14.5 %","1.19 per 1,000 persons","0.01 %","0.5 per 100k persons",1067,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Iraq","Upper middle income","April 01, 2022","14.3 %","0.71 per 1,000 persons","0.01 %","0.3 per 100k persons",371,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Ireland","High income","April 01, 2022","15.7 %","4.34 per 1,000 persons","3.73 %","925.7 per 100k persons",56393,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Isle of Man","High income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Israel","High income","January 23, 2022","4.6 %","12.57 per 1,000 persons","1.13 %","374.8 per 100k persons",45183,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Italy","High income","April 01, 2022","7.3 %","6.82 per 1,000 persons","0.72 %","132.8 per 100k persons",106561,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Ivory Coast","Lower middle income","April 01, 2022","4 %","0.1 per 1,000 persons","0.34 %","0.5 per 100k persons",604,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Ivory Coast","Lower middle income","April 01, 2022","4 %","0.1 per 1,000 persons","0.34 %","0.5 per 100k persons",604,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Jamaica","Upper middle income","December 26, 2021","12.9 %","0.52 per 1,000 persons","0.69 %","20.9 per 100k persons",774,"Does not have access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Japan","High income","April 01, 2022","19.3 %","0.67 per 1,000 persons","3.11 %","151 per 100k persons",231476,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Jordan","Upper middle income","December 27, 2021","6 %","2.72 per 1,000 persons","0.06 %","6.4 per 100k persons",1351,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Kazakhstan","Upper middle income","May 28, 2021","4.8 %","2.65 per 1,000 persons","0.04 %","2.2 per 100k persons",637,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Kenya","Lower middle income","April 01, 2022","9.4 %","0.1 per 1,000 persons","2.46 %","8.4 per 100k persons",7560,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Kiribati","Lower middle income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Kosovo","Upper middle income","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Kuwait","High income","March 10, 2022","6.9 %","3.87 per 1,000 persons","0.09 %","8.2 per 100k persons",467,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Kyrgyzstan","Lower middle income","June 23, 2021","1.5 %","3.44 per 1,000 persons","0.02 %","0.4 per 100k persons",40,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Laos","Lower middle income","No tests reported","Insufficient data","Insufficient data","0.01 %","0.2 per 100k persons",18,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Latvia","High income","April 01, 2022","13.4 %","7.52 per 1,000 persons","1.3 %","486.8 per 100k persons",12682,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Lebanon","Upper middle income","June 23, 2021","6.7 %","2.05 per 1,000 persons","0.09 %","7.9 per 100k persons",1336,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Lesotho","Lower middle income","April 01, 2022","6.1 %","0.46 per 1,000 persons","0.02 %","0.2 per 100k persons",23,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Liberia","Low income","September 26, 2021","6.9 %","0.06 per 1,000 persons","1.33 %","1.4 per 100k persons",77,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Libya","Upper middle income","March 31, 2022","20.1 %","0.68 per 1,000 persons","0 %","0.1 per 100k persons",35,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Libya","Upper middle income","March 31, 2022","20.1 %","0.68 per 1,000 persons","0 %","0.1 per 100k persons",35,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Liechtenstein","High income","No tests reported","Insufficient data","Insufficient data","6.96 %","2486 per 100k persons",987,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Lithuania","High income","April 01, 2022","13.2 %","6.13 per 1,000 persons","3.07 %","924.4 per 100k persons",30866,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Luxembourg","High income","April 01, 2022","8.6 %","7.74 per 1,000 persons","9.12 %","2227.4 per 100k persons",21192,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Macao SAR, China","High income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Madagascar","Low income","March 12, 2022","15.1 %","0.03 per 1,000 persons","0.51 %","0.7 per 100k persons",789,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Malawi","Low income","April 01, 2022","15.2 %","0.05 per 1,000 persons","1.14 %","3 per 100k persons",1050,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Malaysia","Upper middle income","June 16, 2021","5.6 %","2.32 per 1,000 persons","0.22 %","26 per 100k persons",9725,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Maldives","Upper middle income","November 09, 2021","6.4 %","8.45 per 1,000 persons","0.61 %","172.4 per 100k persons",975,"Does not have access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Mali","Low income","April 01, 2022","4.8 %","0.06 per 1,000 persons","0.16 %","0.2 per 100k persons",72,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Malta","High income","September 06, 2021","1.9 %","5.71 per 1,000 persons","1.64 %","162.8 per 100k persons",893,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Marshall Islands","Upper middle income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Mauritania","Lower middle income","March 31, 2022","6.1 %","0.4 per 1,000 persons","0.05 %","0.4 per 100k persons",26,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Mauritius","High income","September 01, 2021","Insufficient data","0.02 per 1,000 persons","0.37 %","60.5 per 100k persons",910,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Mexico","Upper middle income","April 01, 2022","36 %","0.2 per 1,000 persons","1.21 %","31.8 per 100k persons",50385,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Micronesia","Lower middle income","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Moldova","Lower middle income","June 13, 2021","8.4 %","1.09 per 1,000 persons","0.14 %","9.9 per 100k persons",431,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Monaco","High income","No tests reported","Insufficient data","Insufficient data","1.06 %","227.7 per 100k persons",97,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Mongolia","Lower middle income","No tests reported","Insufficient data","Insufficient data","0.08 %","20.9 per 100k persons",794,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Montenegro","Upper middle income","June 21, 2021","10 %","1.82 per 1,000 persons","0.43 %","96.2 per 100k persons",635,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Morocco","Lower middle income","March 31, 2022","11.5 %","0.43 per 1,000 persons","0.06 %","1 per 100k persons",668,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Mozambique","Low income","April 01, 2022","19.3 %","0.07 per 1,000 persons","0.36 %","1.8 per 100k persons",1059,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Myanmar","Lower middle income","April 01, 2022","9.2 %","0.26 per 1,000 persons","0.02 %","0.2 per 100k persons",137,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Myanmar","Lower middle income","April 01, 2022","9.2 %","0.26 per 1,000 persons","0.02 %","0.2 per 100k persons",137,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Namibia","Upper middle income","April 01, 2022","17.8 %","0.69 per 1,000 persons","0.21 %","9.3 per 100k persons",471,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Nauru","High income","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Nepal","Lower middle income","April 01, 2022","21.4 %","0.31 per 1,000 persons","0.2 %","4.7 per 100k persons",1410,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Netherlands","High income","January 25, 2022","16.7 %","3.32 per 1,000 persons","1.12 %","436.9 per 100k persons",100376,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"New Caledonia","High income","September 07, 2021","No cases reported","0.31 per 1,000 persons","0.01 %","3.1 per 100k persons",9,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"New Zealand","High income","April 01, 2022","12.8 %","2.86 per 1,000 persons","1.15 %","152.8 per 100k persons",8841,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Nicaragua","Lower middle income","No tests reported","Insufficient data","Insufficient data","1.12 %","2 per 100k persons",171,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Niger","Low income","March 31, 2022","2.5 %","0.02 per 1,000 persons","2.57 %","0.4 per 100k persons",185,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Nigeria","Lower middle income","March 31, 2022","3 %","0.04 per 1,000 persons","3.46 %","1.5 per 100k persons",4443,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"North Korea","Low income","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"North Macedonia","Upper middle income","February 24, 2022","13.6 %","1.79 per 1,000 persons","0.19 %","16.2 per 100k persons",802,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Northern Mariana Islands","High income","No tests reported","Insufficient data","Insufficient data","Insufficient data","961.8 per 100k persons",688,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Norway","High income","January 22, 2022","9.8 %","3.24 per 1,000 persons","2.61 %","625.4 per 100k persons",44975,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Oman","High income","May 28, 2021","Insufficient data","0.13 per 1,000 persons","0.26 %","11.5 per 100k persons",952,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Pakistan","Lower middle income","April 01, 2022","5 %","0.21 per 1,000 persons","0.21 %","0.8 per 100k persons",2039,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Palau","High income","No tests reported","Insufficient data","Insufficient data","0.32 %","71.5 per 100k persons",13,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Palestine","Lower middle income","February 03, 2022","20 %","0.98 per 1,000 persons","0 %","0.4 per 100k persons",129,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Palestine","Lower middle income","February 03, 2022","20 %","0.98 per 1,000 persons","0 %","0.4 per 100k persons",129,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Panama","High income","April 01, 2022","11.5 %","2.26 per 1,000 persons","0.41 %","38 per 100k persons",2783,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Papua New Guinea","Lower middle income","November 28, 2021","16 %","0.08 per 1,000 persons","7.9 %","32.1 per 100k persons",4301,"Does not have access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Paraguay","Upper middle income","March 27, 2022","25.6 %","0.66 per 1,000 persons","0.16 %","9.4 per 100k persons",1042,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Peru","Upper middle income","March 24, 2022","10.3 %","1.62 per 1,000 persons","0.66 %","39.6 per 100k persons",15389,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Philippines","Lower middle income","March 31, 2022","15.7 %","0.47 per 1,000 persons","0.32 %","8.4 per 100k persons",14309,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Poland","High income","April 01, 2022","15.5 %","1.71 per 1,000 persons","1.48 %","141.7 per 100k persons",61019,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Portugal","High income","April 01, 2022","8.8 %","8.31 per 1,000 persons","0.75 %","204.1 per 100k persons",26646,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Puerto Rico","High income","No tests reported","Insufficient data","Insufficient data","Insufficient data","238.3 per 100k persons",7636,"Has access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Qatar","High income","April 01, 2022","10.8 %","1.6 per 1,000 persons","1.44 %","88.7 per 100k persons",4718,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Republic of the Congo","Lower middle income","March 12, 2022","5.3 %","0.14 per 1,000 persons","2.86 %","7.3 per 100k persons",545,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Republic of the Congo","Lower middle income","March 12, 2022","5.3 %","0.14 per 1,000 persons","2.86 %","7.3 per 100k persons",545,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Romania","High income","March 10, 2022","13 %","2.14 per 1,000 persons","0.42 %","42 per 100k persons",10468,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Russia","Upper middle income","April 01, 2022","7.9 %","3.09 per 1,000 persons","0.08 %","6.8 per 100k persons",14248,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Russia","Upper middle income","April 01, 2022","7.9 %","3.09 per 1,000 persons","0.08 %","6.8 per 100k persons",14248,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Rwanda","Low income","March 31, 2022","2.7 %","0.84 per 1,000 persons","0.35 %","2.8 per 100k persons",727,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Saint Kitts and Nevis","High income","April 01, 2022","9.8 %","2.9 per 1,000 persons","0.67 %","69.1 per 100k persons",39,"Does not have access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Saint Lucia","Upper middle income","March 31, 2022","17.9 %","1.56 per 1,000 persons","0.43 %","43.9 per 100k persons",99,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Saint Vincent and the Grenadines","Upper middle income","July 06, 2021","3.3 %","1.37 per 1,000 persons","1.19 %","87.2 per 100k persons",105,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Saint Vincent and the Grenadines","Upper middle income","July 06, 2021","3.3 %","1.37 per 1,000 persons","1.19 %","87.2 per 100k persons",105,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Saint Vincent and the Grenadines","Upper middle income","July 06, 2021","3.3 %","1.37 per 1,000 persons","1.19 %","87.2 per 100k persons",105,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Samoa","Upper middle income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"San Marino","High income","March 22, 2022","11.6 %","7.35 per 1,000 persons","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"S√£o Tom√© and Pr√≠ncipe","Lower middle income","March 28, 2022","14.9 %","0.31 per 1,000 persons","0.24 %","4 per 100k persons",10,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Saudi Arabia","High income","April 01, 2022","1.4 %","2.08 per 1,000 persons","0.04 %","0.5 per 100k persons",1230,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Senegal","Lower middle income","April 01, 2022","7.8 %","0.1 per 1,000 persons","1.68 %","4.6 per 100k persons",1552,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Serbia","Upper middle income","April 01, 2022","24 %","1.81 per 1,000 persons","0.02 %","3.5 per 100k persons",679,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Seychelles","High income","December 21, 2020","Insufficient data","Insufficient data","1.89 %","692.5 per 100k persons",697,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Sierra Leone","Low income","March 16, 2022","1.4 %","0.09 per 1,000 persons","0.65 %","0.3 per 100k persons",58,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Singapore","High income","September 20, 2021","0.2 %","10.35 per 1,000 persons","1.04 %","198.7 per 100k persons",12891,"Has access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Sint Maarten (Dutch part)","High income","No tests reported","Insufficient data","Insufficient data","Insufficient data","4619.9 per 100k persons",2006,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Slovakia","High income","April 01, 2022","6.7 %","12.96 per 1,000 persons","1.27 %","406.8 per 100k persons",24357,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Slovenia","High income","April 01, 2022","4.8 %","20.4 per 1,000 persons","5.77 %","2092.5 per 100k persons",56904,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Solomon Islands","Lower middle income","No tests reported","Insufficient data","Insufficient data","0.26 %","4.3 per 100k persons",37,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Somalia","Low income","January 10, 2022","4.2 %","0.07 per 1,000 persons","0 %","0 per 100k persons",35,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"South Africa","Upper middle income","April 01, 2022","15.5 %","0.65 per 1,000 persons","1.02 %","36.6 per 100k persons",31678,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"South Korea","High income","October 31, 2021","3.2 %","0.74 per 1,000 persons","0.23 %","60.1 per 100k persons",35835,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"South Korea","High income","October 31, 2021","3.2 %","0.74 per 1,000 persons","0.23 %","60.1 per 100k persons",35835,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"South Sudan","Low income","April 01, 2022","3.1 %","0.06 per 1,000 persons","0.82 %","0.5 per 100k persons",107,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Spain","High income","November 15, 2021","6.7 %","2.47 per 1,000 persons","0.88 %","156 per 100k persons",100910,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Spain","High income","November 15, 2021","6.7 %","2.47 per 1,000 persons","0.88 %","156 per 100k persons",100910,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Sri Lanka","Lower middle income","April 01, 2022","11 %","0.66 per 1,000 persons","0.41 %","10.9 per 100k persons",2665,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Saint Martin","High income","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Sudan","Low income","October 27, 2021","2.7 %","0.04 per 1,000 persons","0.05 %","0 per 100k persons",129,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Suriname","Upper middle income","No tests reported","Insufficient data","Insufficient data","1.11 %","131.6 per 100k persons",1019,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Sweden","High income","May 10, 2021","11.1 %","4.77 per 1,000 persons","7.04 %","1159.9 per 100k persons",172449,"Has access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Switzerland","High income","April 01, 2022","19.5 %","4.67 per 1,000 persons","3.48 %","1160.8 per 100k persons",133136,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Syria","Low income","No tests reported","Insufficient data","Insufficient data","0.2 %","0.4 per 100k persons",74,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Taiwan","High income","April 01, 2022","0.2 %","1.4 per 1,000 persons","0.56 %","0.5 per 100k persons",321,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Taiwan","High income","April 01, 2022","0.2 %","1.4 per 1,000 persons","0.56 %","0.5 per 100k persons",321,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Tajikistan","Low income","March 30, 2020","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Tanzania","Lower middle income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Thailand","Upper middle income","March 31, 2022","18.3 %","0.77 per 1,000 persons","0.37 %","19.6 per 100k persons",14804,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"The Bahamas","High income","April 01, 2022","15.8 %","1.07 per 1,000 persons","0.93 %","56.4 per 100k persons",263,"Does not have access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"The Gambia","Low income","March 24, 2022","6.5 %","0.12 per 1,000 persons","8.78 %","23 per 100k persons",1123,"Has access to sequencing facilities","Does not meet testing target","Meets sequencing target","Test - Increase diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Togo","Low income","April 01, 2022","6 %","0.15 per 1,000 persons","0.63 %","2 per 100k persons",358,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Tonga","Upper middle income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Trinidad and Tobago","High income","July 02, 2021","20.2 %","0.94 per 1,000 persons","1.02 %","94.8 per 100k persons",1400,"Does not have access to sequencing facilities","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Tunisia","Lower middle income","March 31, 2022","22.9 %","0.79 per 1,000 persons","0.07 %","4.8 per 100k persons",858,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Turkey","Upper middle income","April 01, 2022","10.6 %","3.53 per 1,000 persons","0.69 %","93.5 per 100k persons",85245,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Turkmenistan","Upper middle income","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Turks and Caicos Islands","High income","No tests reported","Insufficient data","Insufficient data","0.28 %","25.5 per 100k persons",20,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Tuvalu","Upper middle income","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Uganda","Low income","March 31, 2022","7.6 %","0.1 per 1,000 persons","0.36 %","0.9 per 100k persons",856,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Ukraine","Lower middle income","February 18, 2022","28.2 %","0.79 per 1,000 persons","0.01 %","0.9 per 100k persons",619,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"United Arab Emirates","High income","April 01, 2022","0.4 %","30.56 per 1,000 persons","0.01 %","0.2 per 100k persons",2619,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"United Kingdom","High income","April 01, 2022","4.5 %","15.07 per 1,000 persons","13.09 %","3088.7 per 100k persons",2489683,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"United States of America","High income","April 01, 2022","9.8 %","4.17 per 1,000 persons","4.75 %","706.1 per 100k persons",2829945,"Has access to sequencing facilities","Meets testing target","Meets sequencing target","Sustain - Sustain diagnostic testing capacity","Sustain - Sustain current sequencing levels"
"Uruguay","High income","March 31, 2022","16.9 %","3.68 per 1,000 persons","0.02 %","4.9 per 100k persons",751,"Has access to sequencing facilities","Meets testing target","Does not meet sequencing target","Sustain - Sustain diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Uzbekistan","Lower middle income","July 14, 2020","Insufficient data","Insufficient data","0.04 %","0.2 per 100k persons",88,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Vanuatu","Lower middle income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",1,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Venezuela","Upper middle income","May 30, 2021","Insufficient data","0.02 per 1,000 persons","0.08 %","1 per 100k persons",430,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Venezuela","Upper middle income","May 30, 2021","Insufficient data","0.02 per 1,000 persons","0.08 %","1 per 100k persons",430,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Vietnam","Lower middle income","May 08, 2021","0.6 %","0.03 per 1,000 persons","0.03 %","3.2 per 100k persons",3311,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Vietnam","Lower middle income","May 08, 2021","0.6 %","0.03 per 1,000 persons","0.03 %","3.2 per 100k persons",3311,"Has access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"U.S. Virgin Islands","High income","No tests reported","Insufficient data","Insufficient data","Insufficient data","1612 per 100k persons",1730,"Does not have access to sequencing facilities","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Yemen","Low income","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Does not have access to sequencing facilities","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Zambia","Lower middle income","April 01, 2022","10.8 %","0.32 per 1,000 persons","0.27 %","3.2 per 100k persons",1312,"Has access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Strengthen/Leverage - Strengthen sequencing levels by leveraging existing NGS capacity"
"Zimbabwe","Lower middle income","March 31, 2022","12 %","0.32 per 1,000 persons","0.08 %","1.1 per 100k persons",722,"Does not have access to sequencing facilities","Does not meet testing target","Does not meet sequencing target","Test - Increase diagnostic testing capacity","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"British Indian Ocean Territory","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Cook Islands","No income data","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Falkland Islands","No income data","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"French Southern and Antarctic Lands","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"French Southern and Antarctic Lands","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"French Southern and Antarctic Lands","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Guernsey","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Heard Island and McDonald Islands","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Jersey","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Montserrat","No income data","No tests reported","Insufficient data","Insufficient data","5.16 %","160.6 per 100k persons",10,"Insufficient data","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Niue","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Norfolk Island","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Pitcairn Islands","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Saint Helena","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Saint Pierre and Miquelon","No income data","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Saint-Barth√©lemy","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"South Georgia and the South Sandwich Islands","No income data","No tests reported","Insufficient data","Insufficient data","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
"Wallis and Futuna","No income data","No tests reported","Insufficient data","Insufficient data","7.14 %","27 per 100k persons",10,"Insufficient data","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Anguilla","No income data","No tests reported","Insufficient data","Insufficient data","1.08 %","191.7 per 100k persons",32,"Insufficient data","Insufficient testing data","Meets sequencing target","Insufficient testing data","Sustain - Sustain current sequencing levels"
"Vatican City","No income data","No tests reported","Insufficient data","Insufficient data","0 %","0 per 100k persons",0,"Insufficient data","Insufficient testing data","Does not meet sequencing target","Insufficient testing data","Connect/Build - Connect to countries with NGS capacity or build NGS capacity from scratch"
"Western Sahara","No income data","October 13, 2021","No cases reported","0.03 per 1,000 persons","Insufficient data","Insufficient data",NaN,"Insufficient data","Insufficient testing data","Insufficient data","Insufficient testing data","Insufficient data - Missing key diagnostic or case metrics"
